{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:45:25Z","timestamp":1789969525280,"version":"4.0.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":783,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/ced.12073","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T03:17:09Z","timestamp":1373426229000},"page":"659-664","source":"Crossref","is-referenced-by-count":39,"title":["Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris"],"prefix":"10.1093","volume":"38","author":[{"given":"V. K.","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology; All India Institute of Medical Sciences; New Delhi; India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khandpur","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology; All India Institute of Medical Sciences; New Delhi; India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"10.1111\/ced.12073-BIB0001|ced12073-cit-0001","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus: an update","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1111\/ced.12073-BIB0002|ced12073-cit-0002","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12073-BIB0003|ced12073-cit-0003","first-page":"245","article-title":"Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid","volume":"111","author":"Medved","year":"1974","journal-title":"Can Med Assoc J"},{"key":"10.1111\/ced.12073-BIB0004|ced12073-cit-0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archderm.1997.03890380101016","article-title":"Pulse intravenous cyclophosphamide for treatment of autoimmune blistering diseases: is there an advantage over the oral route?","volume":"133","author":"Werth","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/ced.12073-BIB0005|ced12073-cit-0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D36NS4V35J","article-title":"Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study","volume":"11","author":"Bhat","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1111\/ced.12073-BIB0006|ced12073-cit-0006","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0733-8635(05)70194-7","article-title":"Pulse intravenous cyclophosphamide therapy for dermatologic disorders","volume":"18","author":"Fox","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1111\/ced.12073-BIB0007|ced12073-cit-0007","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12073-BIB0008|ced12073-cit-0008","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1468-3083.2011.04170.x","article-title":"Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study","volume":"26","author":"Ioannides","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/ced.12073-BIB0009|ced12073-cit-0009","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/096120339700600307","article-title":"Side effects of intravenous cyclophosphamide pulse therapy","volume":"6","author":"Martin","year":"1997","journal-title":"Lupus"},{"key":"10.1111\/ced.12073-BIB0010|ced12073-cit-0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhoea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12073","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.12073\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:37:54Z","timestamp":1676367474000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/38\/6\/659\/6623028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12073","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718345186.793493632","asserted-by":"object"}]},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}